COVID-19 and Diabetes: A Call To Action
The COVID-19 pandemic presents humanity with a health crisis as never in the past. And, as in many other instances, people with diabetes are paying a very high price.
Data are, unfortunately, showing that people with diabetes are at higher risk of contracting COVID-19 and that the prognosis is quite poor. Also in the daily management of their disease, because of the restrictions applied by many Governments, they have to face tough challenges in getting needed treatments as well as the required support of specialists and other health-care professionals, all fully engaged in the COVID-19 battle. At the same time, in such a difficult health crisis, they likely are not receiving the most appropriate management when hospitalized.
Diabetes Research and Clinical Practice, with its long affiliation to the International Diabetes Federation, is committed to playing a positive role during this crisis.
We the Editors of DRCP guarantee a fast-track process for any relevant research regarding diabetes and COVID-19 and free access to accepted papers. Our aim is to serve as a quick, trusted and authoritative platform for disseminating new diabetes research relating to the COVID-19 pandemic, with the aim of better serving people with diabetes all around the world.
For all these reasons, with this call, Diabetes Research and Clinical Practice invites scientists from all around the world to submit their research in this field.
Antonio Ceriello, MD
Editor-in-Chief
March, 2020